Nurse Practitioner, Family · West Bloomfield, MI
NPI
1649712183
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
6777 W Maple Rd
West Bloomfield, MI, 48322
Phone (313) 850-5649
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
729 services
Medicare patients, 2024
247
Average age 75
Drug cost, 2024
$2.8M
4,694 prescriptions
Company payments, 2025
$3,438
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kari Anglin was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 116 times for 92 patients. In total Kari Anglin billed 729 services in 18 codes, and Medicare paid $32K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-29.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 116 | 92 | $10.67 | $1,238 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 115 | 88 | $10.77 | $1,239 |
| 99215 Office E&M - Established | Office | 89 | 72 | $95.00 | $8,455 |
| 99215 Office E&M - Established | Facility | 88 | 67 | $92.28 | $8,120 |
| 99214 Office E&M - Established | Facility | 53 | 47 | $56.79 | $3,010 |
| 99214 Office E&M - Established | Office | 47 | 45 | $71.29 | $3,351 |
| 95984 Electrical Nerve Conductivity | Facility | 40 | 18 | $21.69 | $868 |
| 95983 Electrical Nerve Conductivity | Facility | 34 | 20 | $24.84 | $845 |
| 95970 Electrical Nerve Conductivity | Facility | 28 | 22 | $10.63 | $298 |
| 99213 Office E&M - Established | Facility | 27 | 22 | $39.47 | $1,066 |
| 99213 Office E&M - Established | Office | 20 | 18 | $52.70 | $1,054 |
By year: 2022 $36K for 527 services; 2023 $31K for 493 services; 2024 $32K for 729 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kari Anglin prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,145 prescriptions and refills. In total Kari Anglin wrote 4,694 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,145 | 2,768 | 337 | $83K |
| Clonazepam Generic | 262 | 453 | 77 | $3,890 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 249 | 577 | 78 | $26K |
| Amantadine Amantadine Hcl | 217 | 530 | 69 | $13K |
| Rytary Carbidopa/Levodopa | 150 | 348 | 43 | $306K |
| Primidone Generic | 147 | 310 | 40 | $9,205 |
| Nuplazid Pimavanserin Tartrate | 146 | 158 | 20 | $752K |
| Donepezil Hcl Generic | 143 | 300 | 36 | $2,053 |
| Gabapentin Generic | 134 | 273 | 39 | $1,770 |
| Quetiapine Fumarate Generic | 116 | 226 | 32 | $2,005 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 109 | 225 | 39 | $3,298 |
| Topiramate Generic | 107 | 194 | 30 | $1,945 |
| Ropinirole Er Ropinirole Hcl | 92 | 199 | 24 | $16K |
| Ropinirole Hcl Generic | 84 | 210 | 25 | $3,854 |
| Propranolol Hcl Er Propranolol Hcl | 76 | 205 | 27 | $4,118 |
Brand drugs: - claims; generic drugs: 4,087 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kari Anglin $3,438 ($3,438 in general payments such as food, travel and fees) from 9 companies. The largest payer was Medtronic, Inc. with $1,341.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 14 | $1,341 |
| Boston Scientific Corporation BSX | 5 | $605 |
| Abbvie Inc. ABBV | 3 | $371 |
| Supernus Pharmaceuticals, Inc. SUPN | 15 | $315 |
| ACADIA Pharmaceuticals Inc ACAD | 5 | $289 |
| Teva Pharmaceuticals USA, Inc. TEVA | 4 | $197 |
| MDD US Operations, LLC | 1 | $125 |
| Amneal Pharmaceuticals LLC AMRX | 1 | $122 |
| Abbott Laboratories ABT | 1 | $72.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.